How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Background: The Movement Disorder Society criteria for progressive supranuclear palsy define diagnostic allocations, stratified by certainty levels and clinical predominance types. We aimed to study the frequency of ambiguous multiple allocations and to develop rules to eliminate them. Methods: We retrospectively collected standardized clinical data by chart review in a multicenter cohort of autopsy‐confirmed patients with progressive supranuclear palsy, to classify them by diagnostic certainty level and predominance type and to identify multiple allocations. Results: Comprehensive data were available from 195 patients. More than one diagnostic allocation occurred in 157 patients (80.5%). On average, 5.4 allocations were possible per patient. We developed four rules for Multiple Allocations eXtinction (MAX). They reduced the number of patients with multiple allocations to 22 (11.3%), and the allocations per patient to 1.1. Conclusions: The proposed MAX rules help to standardize the application of the Movement Disorder Society criteria for progressive supranuclear palsy. © 2019 International Parkinson and Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Invited review: Neuropathology of tauopathies: principles and practice
Kovacs, G. G. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12208 · Cited by 492
Cited by
Redefining the multidimensional clinical phenotypes of frontotemporal lobar degeneration syndromes
Murley, A. G., Coyle-Gilchrist, I., Rouse, M. A., Jones, P. S., Li, W., Wiggins, J., Lansdall, C., Rodríguez, P. V., Wilcox, A., Tsvetanov, K. A., et al. (2020) · Brain · doi:10.1093/brain/awaa097 · Cited by 162
Self-citationGenetic determinants of survival in progressive supranuclear palsy: a genome-wide association study
Jabbari, E., Koga, S., Valentino, R. R., Reynolds, R. H., Ferrari, R., Tan, M. M. X., Rowe, J. B., Dalgard, C. L., Scholz, S. W., Dickson, D. W., et al. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30394-x · Cited by 111
Self-citationGABAergic cortical network physiology in frontotemporal lobar degeneration
Adams, N. E., Hughes, L. E., Rouse, M. A., Phillips, H. N., Shaw, A. D., Murley, A. G., Cope, T. E., Bevan-Jones, W. R., Passamonti, L., Street, D., et al. (2021) · Brain · doi:10.1093/brain/awab097 · Cited by 47
Self-citationThe evolution of parkinsonism in primary progressive apraxia of speech: a 6-year longitudinal study
Seckin, Z. I., Duffy, J. R., Strand, E. A., Clark, H. M., Utianski, R. L., Machulda, M. M., Botha, H., Ali, F., Thu Pham, N. T., Lowe, V. J., et al. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.09.039 · Cited by 36
Self-citation
Metadata
- Authors
- Grimm, M., Respondek, G., Stamelou, M., Arzberger, T., Ferguson, L., Gelpi, E., Giese, A., Grossman, M., Irwin, D. J., Pantelyat, A., Rajput, A., Roeber, S., van Swieten, J. C., Troakes, C., Antonini, A., Bhatia, K. P., Colosimo, C., van Eimeren, T., Kassubek, J., Levin, J., Meissner, W. G., Nilsson, C., Oertel, W. H., Piot, I., Poewe, W., Wenning, G. K., Boxer, A., Golbe, L. I., Josephs, K. A., Litvan, I., Morris, H. R., Whitwell, J. L., Compta, Y., Corvol, J., Lang, A. E., Rowe, J. B., Höglinger, G. U., & for the Movement Disorder Society‐endorsed PSP Study Group
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2019-03-18
- Volume
- 34
- Issue
- 8
- Pages
- 1228-1232
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2922554235
- Cited by
- 141
- References
- 1
- FWCI
- 9.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.